Figure 1.
Figure 1. Frequency of CD4+CD25high FoxP3+ T cells. (A) Flow cytometric analysis of CD4 and CD25 on peripheral blood–derived T cells from a healthy individual (top panel) and a multiple myeloma (MM) patient (bottom panel). Samples were stained with the appropriate isotype controls (data not shown) or CD4 and CD25 mAbs. CD4+CD25+ T cells were divided into CD25low and CD25high cells according to previously published data. 22,47 Numbers represent percentage of events within the respective rectangle. Settings shown here were used for the analysis of all samples under study. (B) Frequency of CD4+CD25high T cells in 26 healthy donors and 9 MGUS patients, 8 untreated and 2 treated stage I MM patients, 3 untreated and 11 treated stage II MM patients, and 43 treated stage III MM patients. Shown here are median, 75th percentile (box), standard deviation (whiskers), and outliers (dots) (*P < .05, Student t test). (C) Frequency of CD4+CD25high T cells in peripheral blood (PB) and bone marrow (BM) of 6 MM patients. (D) Serial analysis of CD4+CD25high T cells in MM patients at 2 different time points separated by at least 6 months (Tx indicates conventional chemotherapy [n = 3]; SCT, autologous stem cell transplantation [n = 5]; and after SCT, after autologous SCT [n = 5]). (E) Expression of FOXP3 by human CD4+CD25high T cells. CD4+CD25highT cells (dark gray bars) and CD4+CD25– T cells (light gray bars) were sorted by magnetic activated cell sorting (MACS) from peripheral blood in healthy controls (n = 7) and MM patients (n = 6). Real-time RT-PCR for FOXP3 was performed, and relative expression of FOXP3 in CD4+CD25highT cells as well as CD4+CD25– T cells was normalized to GAPDH as described. 22 Error bars represent standard deviation (SD). (F) Flow cytometric analysis of FoxP3 in CD4+CD25highTreg cells in MGUS (n = 8) as well as untreated (n = 7) and treated (n = 13) MM patients compared with healthy donors (n = 14). Shown are the median, 75th percentile (box), standard deviation (whiskers), and outliers (dots). *P < .05, Student t test.

Frequency of CD4+CD25highFoxP3+ T cells. (A) Flow cytometric analysis of CD4 and CD25 on peripheral blood–derived T cells from a healthy individual (top panel) and a multiple myeloma (MM) patient (bottom panel). Samples were stained with the appropriate isotype controls (data not shown) or CD4 and CD25 mAbs. CD4+CD25+ T cells were divided into CD25low and CD25high cells according to previously published data. 22,47  Numbers represent percentage of events within the respective rectangle. Settings shown here were used for the analysis of all samples under study. (B) Frequency of CD4+CD25high T cells in 26 healthy donors and 9 MGUS patients, 8 untreated and 2 treated stage I MM patients, 3 untreated and 11 treated stage II MM patients, and 43 treated stage III MM patients. Shown here are median, 75th percentile (box), standard deviation (whiskers), and outliers (dots) (*P < .05, Student t test). (C) Frequency of CD4+CD25high T cells in peripheral blood (PB) and bone marrow (BM) of 6 MM patients. (D) Serial analysis of CD4+CD25high T cells in MM patients at 2 different time points separated by at least 6 months (Tx indicates conventional chemotherapy [n = 3]; SCT, autologous stem cell transplantation [n = 5]; and after SCT, after autologous SCT [n = 5]). (E) Expression of FOXP3 by human CD4+CD25high T cells. CD4+CD25highT cells (dark gray bars) and CD4+CD25 T cells (light gray bars) were sorted by magnetic activated cell sorting (MACS) from peripheral blood in healthy controls (n = 7) and MM patients (n = 6). Real-time RT-PCR for FOXP3 was performed, and relative expression of FOXP3 in CD4+CD25highT cells as well as CD4+CD25 T cells was normalized to GAPDH as described. 22  Error bars represent standard deviation (SD). (F) Flow cytometric analysis of FoxP3 in CD4+CD25highTreg cells in MGUS (n = 8) as well as untreated (n = 7) and treated (n = 13) MM patients compared with healthy donors (n = 14). Shown are the median, 75th percentile (box), standard deviation (whiskers), and outliers (dots). *P < .05, Student t test.

Close Modal

or Create an Account

Close Modal
Close Modal